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Abstract
Background: The intraoperative placement of an enteral feeding tube (FT) during pancreaticoduodenec-
tomy (PD) is based on the surgeon's perception of need for postoperative nutrition. Published preopera-
tive risk factors predicting postoperative morbidity may be used to predict FT need and associated
intraoperative placement.
Methods: A retrospective review of patients who underwent PD during 2005–2011 was performed by
querying the National Surgical Quality Improvement Program (NSQIP) database with specific procedure
codes. Patients were categorized based on how many of 10 possible preoperative risk factors they
demonstrated. Groups of patients with scores of 1 (low) and 2 (high), respectively, were compared for
FT need, length of stay (LoS) and organ space surgical site infections (SSIs).
Results: Of 138 PD patients, 82 did not have an FT placed intraoperatively, and, of those, 16 (19.5%)
required delayed FT placement. High-risk patients were more likely to require a delayed FT (29.3%)
compared with low-risk patients (9.8%) (P = 0.026). The 16 patients who required a delayed FT had a
median LoS of 15.5 days, whereas the 66 patients who did not require an FT had a median LoS of 8 days
(P < 0.001).
Conclusions: In this analysis, subjects considered as high-risk patients were more likely to require an FT
than low-risk patients. Assessment of preoperative risk factors may improve decision making for selective
intraoperative FT placement.
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Introduction
Pancreaticoduodenectomy (PD), or the Whipple procedure, for
the resection of malignancies of the pancreatic head, ampulla and
distal bile duct is still associated with significant postoperative
morbidity, rates of which range from 30% to 60%.1–4 Commonly
reported morbidities include surgical site and organ space infec-
tions, delayed gastric emptying (DGE), respiratory complications,
and pancreatic fistula.Many of these postoperative complications,
including pancreatic fistula and DGE,may necessitate supplemen-
tary postoperative nutritional support. There is controversy in the
surgical literature regarding the institution of early enteral nutri-
tional support prior to the establishment of adequate oral
feeding.5–9 Additionally, there are no standard recommendations
in pancreatic surgery for the intraoperative placement of an
enteral feeding tube (FT) to initiate early enteral support. Cur-
rently, the decision to place an enteral FT is largely based on the
estimated concern for postoperative enteral feeding needs, as well
as the availability of multidisciplinary FT placement and support
should they be needed postoperatively.
Recent publications indicate that using the patient preoperative
characteristics and comorbidities recorded in the American
College of Surgeons National Surgical Quality Improvement
Program (NSQIP) database may help to identify patients who will
suffer postoperative complications and require an extended length
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of stay (LoS) following PD.10,11 The most contemporary of this
literature, published by Greenblatt et al., identified 10 preopera-
tive risk factors captured within the NSQIP database that were
significantly associated with increased risk for postoperative mor-
bidity.10 The aim of this study was to evaluate whether these same
preoperative risk factors could more accurately guide the decision
to pre-emptively place an enteral FT during the surgical proce-
dure, which would be considered safer and possibly less expensive
than delayed placement. The Huntsman Clinical Cancer Research
PD patient database at the Huntsman Cancer Institute, University
of Utah, and the NSQIP data were retrospectively reviewed to
determine which patients might have benefitted from early enteral
feeding by classifying them according to risk factors. Outcomes




Institutional review board approval granted in March 2011 (UU
#46989) allowed the use of the NSQIP and Huntsman Clinical
Cancer Research databases to identify all patients who underwent
PD during 2005–2011 at the University of Utah and Huntsman
Cancer Institute hospitals. Indications for PD were not restricted
to a specific preoperative diagnosis. Charts were audited for
preoperative demographics and comorbidities, perioperative out-
comes, and nasojejunal FT management. Patients were catego-
rized according to the presence or absence of the following 10
NSQIP preoperative risk factors: preoperative dependent func-
tional status; presence of chronic obstructive pulmonary disease
(COPD); age80 years; male gender; elevated creatinine (mg/dl,
based on laboratory normal ranges, gender-specific); leukocytosis
(k/ml, based on laboratory normal ranges); steroid use; bleeding
disorders; hypoalbuminaemia (3.5 g/dl), and an increased body
mass index (BMI) of25 kg/m2. The BMI cut-off of25 kg/m2 is
based on the published findings of Greenblatt et al.10 Patients in
this analysis who demonstrated none or one of these risk factors
(scores of 1) were considered to be low risk; those who demon-
strated two or more (scores of2) were considered to be high risk
based on a decision by the authors. Variables examined included:
standard demographics (age, gender); FT requirement; use of
total parenteral nutrition (TPN); postoperative complications
[organ space surgical site infection (SSI) rates as defined by the
NSQIP]; 30-day readmission, and hospital mortality.
Surgical approach
Pancreaticoduodenectomies were performed by surgeons with
extensive experience in pancreatic surgery. The operation was per-
formed in either a classic or a pylorus-preserving fashion.
Nutrition
A nasojejunal FT was inserted at the time of surgery, at the sur-
geon’s discretion, or during the postoperative period in patients
who failed to achieve adequate nutrition via oral intake. If possi-
ble, oral feeding was instituted by postoperative day 5 in these
patients regardless of intraoperative FT placement. If an FT was
placed intraoperatively, feedings were initiated at a trophic rate
starting on postoperative day 2 and advanced as required. Feed-
ings were then discontinued if oral feeding was tolerated and
provided sufficient support. Patients in whom an FT had been
placed intraoperatively and who received enteral nutrition to and
beyond postoperative day 9 were considered to have ‘required’
postoperative enteral nutritional support for the purposes of
comparative analysis.
When the FT was placed intraoperatively, the anaesthesiologist
inserted the FT via the nares and advanced the tube under the
direct visualization of the attending surgeon to beyond the most
distal anastomosis. Feeding tubes that were placed during the
postoperative period were most often inserted in the radiology
department under fluoroscopic guidance. A small number of
patients required endoscopic placement by a gastroenterologist or
bedside insertion under fluoroscopy while being treated in the
intensive care unit.
Any patient who received TPN for at least a single day was
considered to have been treated with TPN.
Outcomes
Patients were categorized according to whether the FT was
inserted intraoperatively or postoperatively, and according to their
need for enteral support. Patients were also grouped according to
whether they demonstrated any of the 10 possible preoperative
risk factors.
Data analysis consisted of comparisons between the low- and
high-risk groups to verify relationships with complication rates
and general hospital outcomes (LoS, 30-day readmission). Based
on the determination of need for enteral support, risk groups were
also used to determine possible predictors of need for enteral
support and how these related to the insertion timeframe.
Three separate comparisons were made based on groupings of
FT need and time of placement (Fig. 1).
Costs
Costs related to FT placement were examined. The average cost of
an FT is US$175 (Dobbhoff Tube™; Covidien, Inc., Mansfield,
MA, USA). When an FT is placed intraoperatively, the costs of
doing so include only the cost of the product. When an FT is
placed postoperatively, a fee for the associated procedure must be
taken into account. This amounts to an average of US$325 per
procedure for tubes placed under radiology, and at least US$750
per procedure for tubes placed endoscopically. For the purposes of
this analysis, a procedure fee of US$500 was considered for tubes
placed postoperatively.
Statistics
Data were compiled using Microsoft Excel 2007 (Microsoft Corp.,
Redmond, WA, USA) and analysed using pasw Statistics Version
18.0 (SPSS, Inc., Chicago, IL, USA). Data that were normally
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distributed are reported as the mean  standard deviation (SD)
and percentage. Data that were not normally distributed are
reported as the median and interquartile range (IQR). Based on
differences in the sizes of the analysis groups, univariate analysis
with non-parametric testing using the Mann–Whitney U-test was
performed with continuous variables; categorical variables were
analysed using the chi-squared test or Fisher’s exact test when any
cell count was < 5. The Kruskal–Wallis rank test was used for
continuous variables with more than two groups. A P-value of <
0.05 was considered to indicate statistical significance.
Results
A total of 138 patients underwent PD during 2005–2011.Of these,
67 (48.6%) patients underwent surgery for pancreatic adenocar-
cinoma, 29 (21.0%) for cystic lesions, 19 (13.8%) for an ampullary
or bile duct cancer, 10 (7.2%) for neuroendocrine tumours and
the remaining patients for other pancreas-related diagnoses. The
mean SD age of the patient group was 63.3 12.3 years (range:
25–88 years). Male patients comprised 53.6% (n = 74) of the
population. Mean  SD BMI was 26.6  5.3 kg/m2 (range: 16.3–
46.5 kg/m2). In 90 of the 138 patients (65.2%), a pylorus-
preserving modification of the standard Whipple procedure was
performed. Patients with an American Society of Anesthesiolo-
gists (ASA) score of 3 or 4 comprised 61.6% (n = 85) of the
population. Mean  SD preoperative albumin level (within 30
days of surgery) was 3.89  0.5 g/dl. The incidence of hypoalbu-
minaemia was 21.1% (n = 28). Median hospital LoS was 9 days
(IQR: 8–13 days). Three patients died during the index hospital
admission, giving an overall mortality rate of 2.2%. Thirty of the
135 surviving patients required readmission within 30 days, giving
a readmission rate of 22.2%.
Of the entire sample, 64 (46.4%) patients were categorized as
low risk and 74 (53.6%) as high risk. Sixteen (11.6%) patients had
none of the 10 possible risk factors, 48 (34.8%) had one risk factor
and 47 (34.1%) had two. The highest number of risk factors seen
was five in one patient only. Increased BMI (57.7%, n = 80) and
male gender (53.6%, n = 74) were the most commonly seen risk
factors. Table 1 describes the variables based on when the FT was
inserted.
The first set of comparisons (Fig. 1) analysed outcomes in the
group of patients who did not receive an FT intraoperatively (n =
82). Patients who never required tube placement (n = 66) were
compared with those who did require postoperative tube place-
ment for enteral nutritional support (n = 16). Data are presented
in Table 1.
The second set of comparisons (Fig. 1) involved the 56 patients
in whom an FT was inserted intraoperatively and aimed to evalu-
ate the need for postoperative enteral support. Of the 56 patients,
24 patients (42.9%) were categorized as having ‘required’ enteral
support. Table 2 details comparative data for these 56 patients.
The third set of comparisons (Fig. 1) were carried out in order to
analyse outcomes in all patients who required an FT in compari-
son with outcomes in patients who did not. Data for the 16
patients in whom FTs were placed postoperatively were combined
with data for 24 of the 56 patients in whom FTs were placed
Total sample:
138 patients
No FT in OR: 82 patients
First comparison Second comparison
98 patients did not
require feeds
Third comparison





24 patients required feeds
40 total patients required feeds
32 patients did not
required feeds
Figure 1 Patient flow though the study shows three sets of comparisons among patient groups categorized according to need for feeding
tube and time of tube placement. FT, feeding tube; OR, operating room
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intraoperatively and who were deemed to have ‘required’ the FT,
to give a total of 40 patients (Table 3). Outcomes in this group of
40 patients were then compared with those in the remaining 98
patients, of whom 66 never had an FT and 32 did not ‘require’
their intraoperatively placed FT. Table 3 details the variables for
this comparison.
A comparison based on risk grouping was performed. It
showed that 35.1% (n = 26) of high-risk patients required enteral
nutritional support compared with 21.9% (n = 14) of low-risk
patients (P = 0.087). Table 4 highlights further differences
between the two groups.
Of the 10 NSQIP risk factors used to determine preoperative
risk, the only factor to prove independently significant in terms of
FT need was age 80 years (Table 5). The study sample included
10 patients aged 80 years, six of whom were among the 40
patients who needed an FT; of the 98 patients who did not require
an FT, only four were aged80 years (P = 0.035). This need for an
FT would translate to a relative risk 2.3 times greater in those aged
80 years than in those aged < 80 years.
There were no complications related to FT placement, regard-
less of when the FT was placed. Of the 56 patients in whom FTs
were placed intraoperatively, nine (16.1%) required additional
Table 1 Comparison of preoperative and postoperative demographic variables according to whether feeding tube insertion was intraop-









Age, years, median (IQR) 61.3 (53.3–68.2) 75 (60.0–79.9) 66.3 (55.6–74.0) 0.030
Male gender, n 34 9 31 0.734, 0.672
Body mass index, median (IQR) 26.4 (23.1–28.5) 25.5 (23.5–29.3) 25.9 (21.5–30.5) 0.937
ASA class 3 or 4, n 38 10 37 0.720, 0.337
Albumin 3.5 g/dl, n 7 5 16 0.057, 0.009
Pylorus-preserving surgery, n 47 8 35 0.105, 0.307
High risk, n 29 12 33 0.026, 0.099
Postoperative outcomes
Total parenteral nutrition, n 4 8 15 <0.001, 0.002
Organ space SSI, n 3 5 11 0.006, 0.009
Length of stay, days, median (IQR) 8 (7.0–9.0) 15.5 (12.2–23.2) 10 (8.0–15.0) <0.001
30-day readmission, n 12 6 12 0.091, 0.647
Hospital mortality, n 1 1 1 0.354, 1.000
aIndividual chi-squared test P-values are reported for ‘Never’ versus ‘Postoperative’, and ‘Never’ versus ‘Intraoperative’.
IQR, interquartile range; ASA, American Society of Anesthesiologists; SSI, surgical site infection.
Table 2 Comparison of preoperative and postoperative demographic variables in patients in whom feeding tubes (FTs) were placed
intraoperatively determined according to the use of FTs to postoperative day 9
Needed FT
(n = 24)




Age, years, median (IQR) 69.2 (59.9–75.3) 60.1 (54.9–72.3) 0.065
Male gender, n 12 19 0.485
Body mass index, median (IQR) 25.9 (22.1–32.6) 25.9 (21.1–30.4) 0.541
Albumin 3.5 g/dl, n 6 10 0.697
High risk, n 14 19 0.938
Postoperative outcomes
Total parenteral nutrition, n 10 5 0.029
Organ space SSI, n 8 3 0.041
Length of stay, days, median (IQR) 14 (10.2–16.7) 8 (8.0–10.0) <0.001
30-day readmission, n 5 7 0.990
Hospital mortality, n 1 0 0.429
SSI, surgical site infection; IQR, interquartile range.
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placements by interventional radiology as a result of clogging (n =
2), inadvertent removal (n = 6), and need for a second tube after
oral feeding had been deemed inadequate after the removal of the
first tube (n = 1). Of the 16 patients in whom FTs were placed
postoperatively, eight required more than a single attempt at
placement in order to position the FT correctly, one required the
replacement of a clogged FT, and two required endoscopic place-
ment. Figure 2 outlines costs in a theoretical population of 100
patients.
Discussion
Studies have demonstrated that early postoperative feeding fol-
lowing gastrointestinal surgery can decrease the overall rate of
complications and LoS and aid in wound healing.12–15 Controversy
exists regarding the optimal timing andmethod of administration
of postoperative feeding following PD. Various articles examining
the effects of postoperative nutrition on patients submitted to the
Whipple procedure have come to varying conclusions. A system-
atic review published in 2006 by Goonetilleke and Siriwardena
examined 10 studies investigating nutritional support following
PD.6 Its overall conclusions favoured enteral feeding via a nasoje-
junal FT following PD.6 This article also showed that early man-
datory, postoperative TPN was not associated with improved
outcomes. Moreover, Gianotti et al. found the administration of
TPN to be associated with increased morbidity.16 The review by
Goonetilleke and Siriwardena also implied that administration of
postoperative enteral nutrition helps to decrease infectious com-
plications.6 A 2004 article by Baradi et al. evaluated the effect
of early postoperative enteral feeding on outcomes following
PD.9 This article also supported the provision of early postopera-
tive nasoenteric nutrition because it was associated with lower
readmission rates, complications and decreased TPN use.9
However, there are several case series which are not supportive of
this approach in PD patients, implying an association between
between enteral nutritional supplementation and DGE.8,17
There is no consensus regarding the need for or optimal strat-
egy for enteral feeding support following PD. Given these find-
ings, the present study aimed to identify patients who might
benefit from the intraoperative placement of a nasojejunal FT in
anticipation of the need for postoperative enteral feeding support.
A 2011 article by Greenblatt et al. identified preoperative risk
Table 3 Comparison of preoperative and postoperative demographic variables of feeding tube (FT) need; using overall combined grouping
Needed FT
(n = 40)




Age, years, median (IQR) 70.7 (60.0–78.5) 60.9 (54.4–69.2) 0.003
Male gender, n 21 53 0.866
Body mass index, median (IQR) 25.8 (22.8–30.2) 26.2 (22.7–28.8) 0.733
Albumin 3.5 g/dl, n 11 17 0.158
High risk, n 26 48 0.087
Postoperative outcomes
Total parenteral nutrition, n 18 9 <0.001
Organ space SSI, n 13 6 <0.001
Length of stay, days, median (IQR) 15 (11.2–21.0) 8 (7.0–10.0) <0.001
30-day readmission, n 11 19 0.239
Hospital mortality, n 2 1 0.201
IQR, interquartile range; SSI, surgical site infection.






Needed a feeding tube, % 35.1 21.9 0.087
Non-pylorus-sparing, % 18.8 48.6 <0.001
Organ space SSI, % 10.9 16.2 0.369
ASA scores of 3 or 4, % 51.6 70.3 0.024
Total parenteral nutrition, % 9.4 28.4 0.005
30-day readmission, % 14.0 29.6 0.030
Hospital mortality, % 0.0 4.1 0.248
SSI, surgical site infection; ASA, American Society of Anesthesiologists.
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factors associated with increased morbidity following PD.10 These
risk factors include dependent functional status, older age, male
gender, being overweight or obese, COPD, steroid use, the pres-
ence of a bleeding disorder, preoperative leukocytosis, elevated
serum creatinine and hypoalbuminaemia. These risk factors were
used in an attempt to identify patients whomight benefit from the
intraoperative placement of an FT. Patients were categorized as
being at low or high risk for requiring an FT according to whether
they demonstrated the presence of none or one versus more than
one risk factor.
In this small series, 35.1% of the high-risk patients and 21.9%
of the low-risk patients required enteral nutritional support.
These data showed a trend towards significance in support of the
potential intraoperative placement of FTs in order to avoid diffi-
cult postoperative placements. The analysis of data for subsets of
patients, such as those who needed an FT versus those who did
not, showed that patients who required an FT were more likely to
have a longer LoS, higher rates of organ space SSI and a need for
TPN. It cannot be concluded from these data that high-risk status
alone is an indicator for FT placement, but they may indicate a
potential way to discriminate patients preoperatively for intraop-
erative placement. Operative insertion and stabilization could
avoid a challenging postoperative FT placement, which, as the
present data show, often requires multiple attempts.
Table 5 Distribution of risk factors used to determine risk groups based on overall combined grouping
Needed FT
(n = 40)
Did not need FT
(n = 98)
Dependent functional status, n 0 0
Bleeding disorder, n 2 0
Chronic obstructive pulmonary disease, n 1 2
Steroid medication, n 3 2
Leukocytosis, k/mla, n 1 5
Age 80 years, n 6 4
Elevated creatinine, mg/dlb, n 9 13
Hypoalbuminaemia 3.5 g/dl, n 11 17
Male gender, n 21 53
Body mass index 25 kg/m2, n 23 56
aNormal data based on laboratory site.
bNormal data based on laboratory site and gender.
FT, feeding tube.
54 FTs placed intraoperatively 






29% required postoperative FT placement
= US$13 500 estimated costs2 FTs placed by gastroenterology
@ US$750/FT = US$1500
8 FTs placed by radiology
@ US$500/FT = US$4000
16 FTs placed by radiology












Figure 2 Estimated costs of feeding tube (FT) placement in a theoretical population of 100 patients
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There were complications associated with FT placement arose
and the overall incidence of any complications related to the tubes
was low. Only six of 56 intraoperatively placed FTs clogged
(10.7%). This is relatively low as the literature cites rates of up to
34%.18 The finding that eight of 16 (50.0%) postoperatively placed
FTs required multiple placement attempts was unexpected and is
likely to reflect the complex post-PD anatomy and to highlight the
advantage afforded by intraoperative placement in terms of ability
to place the FT in the appropriate anatomic position. Of the 40
patients who required an FT, 18 (45.0%) eventually required TPN.
The fact that a higher proportion of these patients (eight of 16,
50.0%) belonged to the group in which FTs were placed postop-
eratively may also reflect a failure to place the tube appropriately
in this group. The rate of TPN use may reflect the number of
patients with a pancreatic fistula, who were intolerant of any form
of enteral nutrition, and thus indicates that an intraoperatively
placed FT does not necessarily obviate the need for TPN.
A theoretical analysis was performed to examine costs related to
FT placement. In the postoperative period, nasojejunal FT place-
ment is generally performed under fluoroscopic guidance by an
interventional radiologist or a trained technician, or by a gastro-
enterologist using endoscopic placement. These procedures can be
timely, add a procedure cost, and can increase morbidity.18
Although no additional complications arose as a result of FT
placement in the current study, half of the postoperatively placed
tubes required multiple attempts at placement for appropriate
positioning. Costs were hypothesized in a theoretical population
of 100 patients and costs of empiric placement in high-risk
patients were compared with costs in the theoretical group of
high-risk patients who would require postoperative placement
(Fig. 2). This exercise resulted in estimated potential cost savings
of US$4050 for a population of 100 patients or US$75 per high-
risk patient, with empiric placement.
This review is subject to the limitations of a small retrospective
review. Rates of DGE were not evaluated because surgeons at the
study center do not routinely place nasogastric tubes postopera-
tively, and the most recent definition of DGE proposed by the
International Study Group of Pancreatic Surgery (ISGPS) is
dependent on nasogastric tube output volume.19,20 Presumably,
the majority of patients who required and benefitted from enteral
support had some degree of DGE. The other disadvantage of this
study refers to its inability to measure the possible benefits of early
enteral nutrition as a result of the small size of the study popula-
tion and low complication rate. Additionally this review of peri-
operative predictive factors was limited to those morbidities and
patient demographics screened for in the NSQIP database. Other
patient or intraoperative characteristics may also affect the need
for an enteric FT.
In this retrospective review, patients with two or more preop-
erative risk factors were more likely to require FT placement and
those aged 80 years had significantly higher risk for FT need.
Patients who required an FT had a longer LoS and an increased
complication rate. These data support the notion that selective
intraoperative FT placement for at-risk patients may potentially
benefit patients, as well as reduce costs. In conclusion, surgeons
should consider selective intraoperative enteral FT placement in
all patients aged 80 years and in any patients with two or more
of the preoperative comorbidity risk factors.
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